TABLE 5.
Multivariable Cox analyses: discontinuation with age, phenotype category, sex, and inhibitor/inducer use
Multivariable Cox Models – Fast Phenotype Group | ||||||
---|---|---|---|---|---|---|
Overall |
0 to 2 years |
0 to 4 years |
||||
HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | |
Age (per decade) | 0.87 (0.78, 0.96) | .008a | 0.87 (0.78, 0.96) | .009a | 0.87 (0.78, 0.97) | .011a |
Sex (male vs female) | 1.09 (0.80, 1.49) | .58 | 1.10 (0.81, 1.50) | .54 | 1.10 (0.81, 1.50) | .56 |
Charlson comorbidity index | 1.06 (1.00, 1.12) | .069 | 1.06 (1.00, 1.12) | .064 | 1.06 (1.00, 1.12) | .062 |
Inducer/inhibitor | 0.63 (0.28, 1.43) | .27 | 0.55 (0.23, 1.33) | .18 | 0.54 (0.22, 1.33) | .18 |
Multivariable Cox Models – Middle Phenotype Group | ||||||
---|---|---|---|---|---|---|
Overall |
0 to 2 years |
0 to 4 years |
||||
HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | |
Age (per decade) | 0.92 (0.85, 0.98) | .014a | 0.91 (0.85, 0.98) | .009a | 0.91 (0.85, 0.98) | .011a |
Sex (male vs female) | 0.92 (0.70, 1.21) | .56 | 0.93 (0.71, 1.22) | 0.59 | 0.92 (0.70, 1.20) | .53 |
Charlson comorbidity index | 1.03 (0.98, 1.08) | .19 | 1.04 (0.99, 1.09) | .17 | 1.03 (0.98, 1.09) | .19 |
Inducer/inhibitor | 1.56 (1.09, 2.24) | .014a | 1.49 (1.04, 2.13) | .030a | 1.50 (1.05-2.15) | .026a |
Multivariable Cox Models –Slow Phenotype Group (n = 24, so only 2 variables) | ||||||
---|---|---|---|---|---|---|
Overall |
0 to 2 years |
0 to 4 years |
||||
HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | |
Age (per decade) | 0.93 (0.70, 1.23) | .59 | 0.92 (0.70, 1.21) | .55 | 0.93 (0.71, 1.23) | .61 |
Inhibitor/inducer | 6.04 (2.47, 14.80) | <.001a | 4.85 (2.07, 11.39) | <.001a | 4.77 (2.05, 11.11) | <.001a |
p-value < .05.